Cargando…
Oral Corticosteroid Reduction Between Biologics Initiated and Non-Initiated Patients with Severe Asthma
PURPOSE: The oral corticosteroid (OCS)-sparing effect of several biologics (BIOs) has been shown in clinical trials. To date, no study has evaluated differences in OCS dose reduction between BIO-initiated and BIO-non-initiated patients in real-world clinical practice. We compared dose reductions in...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438425/ https://www.ncbi.nlm.nih.gov/pubmed/37600852 http://dx.doi.org/10.2147/JAA.S411404 |